# National Research Corporation (NRC) Stock Analysis: High Return on Equity Offers Intriguing Investment Potential

- Link: https://www.directorstalkinterviews.com/national-research-corporation-nrc-stock-analysis-high-return-on-equity-offers-intriguing-investment-potential/4121205653
- Published: 2025-07-03T10:31:58+01:00
- Author: Madison Wilson

National Research Corporation (NRC) is a prominent player within the healthcare 
sector, specifically in health information services, a niche that is becoming increasingly
vital as healthcare organizations strive to enhance patient and employee experiences.
Headquartered in Lincoln, Nebraska, NRC provides a suite of analytics and insights
solutions that are subscription-based, offering healthcare providers essential tools
to measure and improve various aspects of patient care and organizational efficiency.

Currently trading at $16.54 with a slight recent dip of 0.01%, NRC’s stock price
has shown a wide range over the past year, fluctuating between $10.13 and $26.17.
This volatility may present an opportunity for investors looking to capitalize on
price movements within this range.

Despite the absence of traditional valuation metrics such as Price-to-Earnings (
P/E), Price-to-Book (P/B), and Price-to-Sales (P/S), NRC stands out with an impressive
Return on Equity (ROE) of 72.69%. This figure suggests that the company is exceptionally
efficient at generating profits from shareholders’ equity, a positive sign for potential
investors. However, the company’s revenue growth has seen a decline of 5%, which
may raise questions about its growth trajectory and market dynamics.

The company’s free cash flow stands at $9,853,750, indicating a healthy cash position
that supports its operations and dividend payments. With a dividend yield of 2.86%
and a payout ratio of 47.06%, NRC offers investors a stable income stream, which
is particularly appealing in uncertain market environments.

NRC’s technical indicators reveal that its stock is currently trading close to its
200-day moving average of $16.57, with a 50-day moving average of $14.20. The Relative
Strength Index (RSI) is at 66.28, suggesting that the stock is nearing overbought
territory, which investors should monitor closely.

Interestingly, there are currently no analyst ratings or price targets available
for NRC, which may indicate that the stock is flying under the radar of major investors
and analysts. This lack of coverage could present a unique opportunity for individual
investors willing to conduct their own due diligence.

NRC’s innovative approach, including the development of Huey AI, a healthcare experience
management companion, positions it well within a rapidly evolving healthcare landscape.
As healthcare providers increasingly prioritize patient and employee experience,
NRC’s solutions could become indispensable, driving future growth.

Given the current market cap of approximately $376.87 million, NRC is a small-cap
stock, often associated with higher risk but also with the potential for significant
upside. Investors who are comfortable with volatility and are optimistic about the
healthcare sector’s digital transformation may find NRC an intriguing addition to
their portfolios. As always, thorough research and an understanding of one’s risk
tolerance are essential when considering an investment in NRC.

Share on: